Cladribin- und Guselkumab-200-mg-Arzneimittel

This tender by Fakultní nemocnice Hradec Králové (University Hospital Hradec Králové) is for the supply of immunosuppressive agents containing cladribine and guselkumab 200 mg over a period until 2029 (Lot 1: cladribine until 12 Feb 2029, Lot 2: guselkumab until 7 Feb 2028). The procedure is an open tender with award based solely on lowest price (100% weight). The total estimated value is CZK 21,339,100 (approx. EUR 882,000). Bidders may submit for both lots. Electronic submission is required. The notice is a correction (update/add) of an earlier notice (394469-2026). No procurement documents beyond the notice were analyzed. Key concerns: short submission deadline (approx. 1 month), missing eligibility criteria and required documents, and inconsistency in EU funding flag (XML indicates no EU funds, structured data says EU-funded).